PMBCX
Price
$35.27
Change
-$0.56 (-1.56%)
Updated
Nov 13 closing price
Net Assets
31.99B
PSKCX
Price
$43.32
Change
-$1.27 (-2.85%)
Updated
Nov 13 closing price
Net Assets
874.73M
Interact to see
Advertisement

PMBCX vs PSKCX

Header iconPMBCX vs PSKCX Comparison
Open Charts PMBCX vs PSKCXBanner chart's image
Principal MidCap C
Price$35.27
Change-$0.56 (-1.56%)
VolumeN/A
Net Assets31.99B
Virtus KAR Mid-Cap Growth C
Price$43.32
Change-$1.27 (-2.85%)
VolumeN/A
Net Assets874.73M
PMBCX vs PSKCX Comparison Chart in %
View a ticker or compare two or three
VS
PMBCX vs. PSKCX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMBCX is a Buy and PSKCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMBCX has more cash in the bank: 32B vs. PSKCX (875M). PMBCX (0.00) and PSKCX (0.00) have matching dividends . PMBCX was incepted earlier than PSKCX: PMBCX (19 years) vs PSKCX (25 years). PSKCX (2.04) is less costly to investors than PMBCX (1.75). PSKCX is a more actively managed with annual turnover of: 13.00 vs. PMBCX (10.50). PMBCX has a lower initial minimum investment than PSKCX: PMBCX (1000) vs PSKCX (2500). PSKCX annual gain was more profitable for investors over the last year : -4.46 vs. PMBCX (-6.40). PMBCX return over 5 years is better than : 21.54 vs. PSKCX (-8.27).
PMBCXPSKCXPMBCX / PSKCX
Total Expense Ratio1.752.0486%
Annual Report Gross Expense Ratio1.752.0486%
Fund Existence19 years25 years-
Gain YTD2.0800.632329%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets32B875M3,657%
Annual Yield % from dividends0.000.00-
Returns for 1 year-6.40-4.46144%
Returns for 3 years28.7021.80132%
Returns for 5 years21.54-8.27-260%
Returns for 10 years77.64149.3852%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GANX2.950.27
+10.07%
Gain Therapeutics
MSIF12.230.15
+1.24%
MSC Income Fund Inc.
LOGI121.131.16
+0.97%
Logitech International SA
ALBT2.000.01
+0.50%
Avalon GloboCare Corp
WB10.57-0.14
-1.31%
Weibo Corp